Molecular basis of V-ATPase inhibition by bafilomycin A1

被引:0
作者
Rong Wang
Jin Wang
Abdirahman Hassan
Chia-Hsueh Lee
Xiao-Song Xie
Xiaochun Li
机构
[1] University of Texas Southwestern Medical Center,Department of Molecular Genetics
[2] University of Texas Southwestern Medical Center,Eugene McDermott Center for Human Growth and Development
[3] St. Jude Children’s Research Hospital,Department of Structural Biology
[4] University of Texas Southwestern Medical Center,Department of Biophysics
来源
Nature Communications | / 12卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Pharmacological inhibition of vacuolar-type H+-ATPase (V-ATPase) by its specific inhibitor can abrogate tumor metastasis, prevent autophagy, and reduce cellular signaling responses. Bafilomycin A1, a member of macrolide antibiotics and an autophagy inhibitor, serves as a specific and potent V-ATPases inhibitor. Although there are many V-ATPase structures reported, the molecular basis of specific inhibitors on V-ATPase remains unknown. Here, we report the cryo-EM structure of bafilomycin A1 bound intact bovine V-ATPase at an overall resolution of 3.6-Å. The structure reveals six bafilomycin A1 molecules bound to the c-ring. One bafilomycin A1 molecule engages with two c subunits and disrupts the interactions between the c-ring and subunit a, thereby preventing proton translocation. Structural and sequence analyses demonstrate that the bafilomycin A1-binding residues are conserved in yeast and mammalian species and the 7’-hydroxyl group of bafilomycin A1 acts as a unique feature recognized by subunit c.
引用
收藏
相关论文
共 115 条
[1]  
Stransky L(2016)The function of V-ATPases in cancer Physiol. Rev. 96 1071-1091
[2]  
Cotter K(2015)Recent Insights into the structure, regulation, and function of the V-ATPases Trends Biochem Sci. 40 611-622
[3]  
Forgac M(2007)Vacuolar ATPases: rotary proton pumps in physiology and pathophysiology Nat. Rev. Mol. Cell. Biol. 8 917-929
[4]  
Cotter K(2017)Breaking up and making up: the secret life of the vacuolar H(+) -ATPase Protein Sci. 26 896-909
[5]  
Stransky L(2018)V-ATPases and osteoclasts: ambiguous future of V-ATPases inhibitors in osteoporosis Theranostics 8 5379-5399
[6]  
McGuire C(2009)V-ATPase functions in normal and disease processes Pflug. Arch. 457 589-598
[7]  
Forgac M(2020)A SARS-CoV-2 protein interaction map reveals targets for drug repurposing Nature 583 459-468
[8]  
Forgac M(2020)Structure and roles of V-type ATPases Trends Biochem Sci. 45 295-307
[9]  
Oot RA(2020)A "Sugar-Coated" proton pump comes into focus: high-resolution structure of a human V-ATPase Mol. Cell 80 379-380
[10]  
Couoh-Cardel S(2020)Structure of V-ATPase from the mammalian brain Science 367 1240-1246